The federal cabinet’s recent decision to increase the cost of 146 life-saving medications is a big, if divisive, step towards solving the long-standing drug pricing problem. A price increase was unavoidable after multiple rounds of negotiations. Subsidies in addition to this targeted increase may lessen the impact on customers. A more nuanced approach must be taken, even though the price increase is an appropriate response to the current economic situation. A healthcare system where everyone, regardless of financial situation, has affordable and easy access to life-saving medications should be the ultimate goal.
